SCHEMBL21669804

SCHEMBL21669804

CCS(=O)(=O)N1CCC[C@H](C(=O)Nc2ccc(C(F)(F)F)c(F)c2)C1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.54
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
LMNA P02545 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
GAA P10253 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
ELOVL6 Q9H5J4 1/20 0.51
MAPT P10636 2/20 0.50
NPSR1 Q6W5P4 1/20 0.50
EPHX2 P34913 1/20 0.50
ALDH1A1 P00352 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21670281 1.00 TP53 (0.54) TP53MEN1KMT2ALMNACYP1A2
SCHEMBL21670280 0.91 SMN1; SMN2 (0.62) MEN1KMT2ALMNACYP1A2CYP3A4
SCHEMBL21669775 0.91 SMN1; SMN2 (0.62) MEN1KMT2ALMNACYP1A2CYP3A4
SCHEMBL21669811 0.88 LMNA (0.59) TP53MEN1KMT2ALMNAGAA
SCHEMBL21670309 0.88 LMNA (0.59) TP53MEN1KMT2ALMNAGAA
SCHEMBL21669813 0.85 TP53 (0.56) TP53MEN1KMT2ALMNACYP1A2
SCHEMBL21670501 0.85 TP53 (0.56) TP53MEN1KMT2ALMNACYP1A2
SCHEMBL21669810 0.83 MAPT (0.62) TP53MEN1KMT2ALMNAGAA
SCHEMBL21669865 0.83 MAPT (0.62) TP53MEN1KMT2ALMNAGAA
SCHEMBL21670294 0.82 EPHX2 (0.64) LMNASMN1; SMN2MAPTNPSR1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020028482-A1 SMALL MOLECULES THAT SENSITIZE HIV-1 INFECTED CELLS TO ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2020-02-06 WO disclosed